Successes

  • Screen Shot 2018-08-01 at 4.30.25 PM
    Philadelphia Court of Common Pleas Judge Arnold L. New has ordered two Risperdal cases to proceed in a new trial for punitive damages. In both cases, causation and compensatory damage were already awarded the plaintiffs– Stange v. Janssen Pharmaceuticals ($500,000) and Murray v. Janssen Pharmaceuticals ($1.75M later reduced to $680,000). Judge New previously ruled in agreement with Janssen
  • Superlawyers 2018 Cropped
    Super Lawyers has again recognized the attorneys of Sheller P.C. in 2018. Founder Stephen A. Sheller has been selected by the organization for the fifteenth consecutive year. Attorney Jamie L. Sheller have been awarded the honor multiple years, including 2018. Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas across the country, representing those who have
  • legal,intelligencer
    In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling prohibited punitive damages.  Boys and young men who developed gynecomastia, female-like breasts, from taking the antipsychotic drug and whose cases had already been tried will
  • Screen Shot 2017-06-09 at 4.58.00 PM
    Sheller PC's $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy who grew female-like breasts after taking the antipsychotic drug Rispderal. The unprecedented $70 Million verdict in damages for physical disfigurement and emotional distress exceeds the verdict in fo
  • A Philadelphia jury awarded $500,000 in compensatory damages to a young man who claimed he grew female-like breasts after taking the antipsychotic drug Risperdal. The jury deliberated six hours before finding the manufacturers of Risperdal, Janssen Pharmaceuticals (a division of Johnson & Johnson), failed to warn health care providers and patients of a condition called gynecomastia which ca